Quote:BREAKING: 51 Million-Person Study Finds COVID-19 “Vaccines” Increase Risk of Respiratory Infections by up to 559%


Landmark study of the ENTIRE South Korean population reveals a VAIDS signal — a dose-dependent rise in the common cold, upper-respiratory infections, pneumonia, and tuberculosis among the vaccinated.

Those that received 4+ COVID shots suffered:

?Common Cold ↑ +559% (children 0–19)

?Upper-Respiratory Infections ↑ +83% (children 0–19)

?Pneumonia ↑ +91% (COVID-negative group)

?Tuberculosis ↑ +35% (COVID-positive group)

Even after adjusting for age, sex, income, comorbidities, prior infection, and time since vaccination, the dose-response trend remained linear and unmistakable.

These findings point to immune exhaustion, IgG4 dominance, and secondary immunodeficiency following repeated mRNA exposure — consistent with vaccine-acquired immune dysregulation (VAIDS).

Apparent reductions in Influenza-Like Illness (ILI) and Pertussis are almost certainly statistical artifacts driven by healthy-user bias, diagnostic-coding overlap, and case misclassification. Crucially, the study’s national ARIMAX time-series revealed a 46-fold surge in confirmed pertussis cases across Korea during 2023, directly contradicting any notion of real-world protection.

Because the “control” group included single-dose recipients, the true increase relative to the completely unvaccinated population is likely even greater than reported.

Across an entire national dataset, each additional COVID-19 “vaccine” dose corresponded to a higher probability of non-COVID respiratory infection — most severely among children.

This study reveals that COVID-19 “vaccines” have eroded immune function across an entire country — and likely the entire globe.

Quote:VAIDS Explains Why EIGHT Studies Show mRNA Booster Shots Dramatically increase Infection Risk

1️⃣Dorr et al - Study of 1,745 healthcare workers finds mRNA boosters raise risk of influenza-like illness (flu, COVID, other viruses) by up to 70% and increase workdays lost by 50%.

2️⃣Shrestha et al (Cleveland Clinic) – The risk of COVID-19 increased with the number of vaccine doses received. Individuals with one prior dose had a 107% higher risk (HR = 2.07, 95% CI: 1.70–2.52), while those with more than three doses faced a 253% higher risk (HR = 3.53, 95% CI: 2.97–4.20).

3️⃣Feldstein et al (CDC) – Children vaccinated with Pfizer-BioNTech without prior SARS-CoV-2 infection were 159% more likely to get infected (HR = 2.59, 95% CI: 1.27–5.28) and 257% more likely to develop symptomatic COVID-19 (HR = 3.57, 95% CI: 1.10–11.63) compared to unvaccinated children without prior infection.

4️⃣Perez et al - More mRNA doses → more IgG4 (↑11x) → higher risk of infection (↑1.8x).

5️⃣Ioannou et al – Vaccine effectiveness (VE) against documented SARS-CoV-2 infection was -3.26% (95% CI, -6.78% to -0.22%), meaning vaccinated individuals had a statistically significant higher infection rate than the unvaccinated control group.

6️⃣Nakatani et al – Vaccinated individuals had an 85% increased odds of infection compared to the unvaccinated (OR = 1.85, 95% CI: 1.33–2.57).

7️⃣Eythorsson et al – Those who received two or more doses had a 42% higher risk of reinfection than those with one dose or less (95% CI: 1.13–1.78).

8️⃣Chemaitelly et al – The effectiveness of Pfizer-BioNTech (BNT162b2) against symptomatic BA.1 and BA.2 Omicron infections dropped from 46.6% and 51.7% (1–3 months post-dose) to -17.8% and -12.1% (≥7 months). Moderna (mRNA-1273) declined from 71.0% and 35.9% to -10.2% and -20.4% over the same period.

Quote:In November of last year, Colorado healthcare workers at Denver Health received doses of a live Ebola vaccine.

Hospital officials said the Regional Emerging Special Pathogen Treatment Center team became some of the first to receive Merck’s ‘ERVEBO’ Ebola jab, for “preventative measures in case of a future outbreak.”

ERVEBO Ebola Vaccine’s ‘Shedding’ Problem

The U.S. Food and Drug Administration’s (FDA) package insert for ERVEBO states that the vaccine “shed[s]” in 31.7% of the vaccinated and for up to 20 days after vaccination.
This means that vaccinated individuals could spread the vaccine virus to those around them.
“Vaccine virus RNA has been detected in blood, saliva, urine, and fluid from skin vesicles of vaccinated individuals,” the insert reads. “In Study 6, 31.7% (19/60) of participants 12 months through 17 years of age enrolled in a substudy shed vaccine virus in saliva following vaccination.”

This shedding problem raises questions about Africa’s 2016, 2018, 2020, 2021, and 2022 Ebola outbreaks that occurred after vaccination campaigns were carried out in those areas.

Given the established record of Ebola outbreaks following earlier vaccination campaigns in the same regions, concerns are raised about a future outbreak in Colorado—situated in the central U.S.—spreading across the country and perhaps the world.

Quote:New Bat Lab Just Down the Road from Denver Health

Meanwhile, a new $12 million, U.S.-taxpayer-funded lab is being built in Fort Collins, Colorado, just 65 miles north of Denver Health, where healthcare workers received the Ebola vaccine “in case of a future outbreak.”
The lab will import bats from around the world and experiment on dangerous diseases, according to The Daily Mail.
Proposals for the 14,000 sqft facility indicate the lab could store and study some of the most deadly or transmissible pathogens on the planet, including Ebola, Nipah virus, and COVID-19.
The project is a collaboration between Dr. Anthony Fauci’s old department at the National Institutes of Health (NIH), Colorado State University (CSU), and EcoHealth Alliance (EHA).
EcoHealth is the controversial New York-based research group at the center of the COVID lab leak theory led by Dr. Peter Daszak, who channeled millions of American taxpayer dollars to fund risky gain-of-function research on bats at the Wahn Institute of Virology (WIV) in Wuhan, China.
The WIV laboratory is argued to be ground zero for the coronavirus pandemic.

Quote:Net Zero advocates propose ticks to induce red meat allergy as climate solution sparking backlash

Two ethics professors at Western Michigan University’s Homer Stryker MD School of Medicine, Parker Crutchfield and Blake Hereth, have ignited outrage with a peer-reviewed paper proposing the deliberate promotion of ticks to trigger alpha-gal syndrome (AGS)—a red-meat allergy—to reduce meat consumption and combat climate change. Published in Bioethics, their “Beneficial Bloodsucking” argument frames AGS as a “moral bioenhancer,” asserting that inducing allergies to cattle, pigs and lambs could ethically “prioritize planetary health over personal choice.” The controversial stance has drawn sharp criticism, with opponents calling it a dangerous confluence of pseudo-science and ideological overreach.

Quote:Prayer Hands Decoded: The Science Behind Humanity's Most Sacred Gesture


[b]The most advanced healing technology on Earth costs nothing, requires no training, and you've been carrying it since birth. You've probably used it without knowing what it does.
[/b]

Press your palms together right now.
Feel that warmth spreading between them? That subtle tingling, as if something invisible is gathering in the space between your skin?
You've just created what researchers in bioelectromagnetic medicine call a 'coherent field node'—a zone where the measurable electromagnetic emissions from your left and right hands create an interference pattern. The HeartMath Institute has documented that when you bring your hands to your chest and press them together, you're positioning them at the peak intensity of your heart's electromagnetic field, creating measurable increases in heart rate variability coherence—a state associated with optimal physiological function.¹
But here's where the New Biophysics gets interesting—and admittedly controversial.
The Scalar Wave Bridge: Where Measured Meets Mystery

When two coherent electromagnetic waves meet in perfect opposition (what physicists call 'destructive interference'), the standard model says they should cancel out. But researchers like Tom Bearden and Konstantin Meyl propose something else happens: the transverse electromagnetic components cancel, yes, but the energy doesn't disappear. Instead, it transforms into what Tesla called 'longitudinal waves' and what modern researchers term 'scalar waves'—a different form of electromagnetic potential that mainstream physics is only beginning to acknowledge.²
According to this model, documented in peer-reviewed journals like the International Journal of Applied and Advanced Scientific Research, when your hands—each carrying opposite bioelectric charges due to hemispheric brain dominance—come together, you create the precise conditions for scalar wave formation: two coherent biological oscillators meeting in phase opposition.³
Whether we call these measured effects 'scalar waves,' 'longitudinal waves,' or simply 'coherent biofields,' the phenomenon is real and measurable. Thermographic imaging shows palm temperature can increase by 1-3°C during prayer mudra, beyond what simple circulation changes would cause.⁴ SQUID magnetometers have detected changes in the biomagnetic field during qigong 'energy ball' exercises between the hands.⁵ The debate isn't whether something happens when you press your palms together—instruments clearly show it does. The debate is about the exact mechanism and whether it represents a new form of biological information transfer that conventional electromagnetic theory doesn't fully explain.



A More Honest Framework

Let me be clear about what we're exploring here: The 'New Biophysics' isn't a rejection of conventional biology—it's an expansion. Just as quantum mechanics didn't invalidate Newton's laws but showed they were a special case of something larger, researchers in biofield science are suggesting that our current understanding of bioelectromagnetics might be incomplete.
The scalar wave hypothesis is one attempt to explain measurable phenomena that don't quite fit the standard model:

• Distant healing effects that aren't blocked by Faraday cages⁶
  
• Biological responses to extremely weak fields that shouldn't be detectable above thermal noise⁷
  
• The persistent organization of living systems that seems to violate thermodynamic predictions⁸
  
• The documented effects of intention on random number generators and biological systems⁹
  

We're in the position of 19th-century physicists observing the photoelectric effect before Einstein—we can measure something happening, but our theoretical framework hasn't quite caught up. The prayer hands phenomenon sits right at this intersection of the known and unknown, the measured and the mysterious.

Quote:Covid ‘Vaccines’
Frank Bergman
August 5, 2025 - 12:54 pm

A California nurse has come forward with explosive whistleblower claims to expose an alarming cover-up of surging fetal deaths caused by Covid mRNA “vaccination” among pregnant women.
The allegations were revealed in court filings for a shocking new lawsuit filed by registered nurse Michelle Spencer.
The lawsuit, filed in California, reveals bombshell claims of institutional misconduct at Community Health System (dba Community Medical Centers, or CMC).
Spencer, a labor and delivery nurse, accuses CMC of concealing a dramatic increase in fetal deaths following the hospital’s Covid “vaccine” policies, implemented in 2021.
The lawsuit alleges fraudulent concealment of adverse outcomes, retaliation against whistleblowers, and prioritization of institutional profits over patient safety.
The lawsuit, Spencer v. Community Health System (Case No. 25CECG03557), claims that the health system concealed an alarming rise in fetal deaths after Covid mRNA injections were mandated for pregnant women.
Spencer, who worked at CMC’s Community Regional Medical Center (CRMC), alleges that the hospital failed to investigate Covid shot-related causes for the devastating increase in stillbirths, a move that, according to the lawsuit, violated ethical and legal standards.

According to Spencer, fetal deaths surged by up to 5,000% among pregnant women who received mRNA injections.
Spencer’s complaint alleges that fetal deaths at CRMC surged dramatically starting in the spring of 2021.
She reveals that fetal deaths went from a baseline of 1–2 per month to an average of 4 per week, coinciding with the rollout of the Covid “vaccines.”
Spencer claims that internal hospital data and staff discussions pointed to the fact that nearly all of these deaths occurred in “vaccinated” mothers.
The lawsuit includes evidence from OB/GYN Dr. James A. Thorp.
Dr. Thorpe prepared a stillbirth rate chart to highlight the surge.
The chart shows that the stillbirth rate in one California hospital jumped from the national average of approximately 5.7 per 1,000 births before 2021 to a staggering 29.3 per 1,000 births after July 2021.
The doctor notes that stillbirths skyrocketed following the introduction of the Covid injections.

Quote:    A rapidly spreading outbreak of chikungunya fever has gripped southern China, with over 4,000 confirmed cases since early July. Yet the Chinese Communist Party (CCP) appears to be downplaying the crisis while enforcing costly quarantines on infected citizens.
   
    Originating in Foshan city in Guangdong Province, the mosquito-borne virus has now reached Guangzhou, Yangjiang and even the capital Beijing – raising fears of a wider epidemic. Local residents report being forced into mandatory hospital isolation at their own expense, a policy that echoes the CCP's controversial Wuhan coronavirus (COVID-19) lockdowns. With China's history of suppressing health data, the true scale of the outbreak remains uncertain.

Quote:    FDA Approves Vimkunya (chikungunya vaccine, recombinant) for Prevention of Disease Caused by Chikungunya Virus COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved Vimkunya (Chikungunya Vaccine, Recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older.

Quote:    VLPs are useful as vaccines. VLPs contain repetitive, high density displays of viral surface proteins that present conformational viral epitopes that can elicit strong T cell and B cell immune responses.[sup][16][/sup] The particles' small radius of roughly 20-200 nm allows sufficient draining into lymph nodes. Since VLPs cannot replicate, they provide a safer alternative to attenuated viruses. VLPs were used to develop FDA-approved vaccines for Hepatitis B and human papillomavirus, which are commercially available.[sup][17][/sup]

Quote:    Therapeutic and imaging agents - VLPs are a candidate delivery system for genes or other therapeutics.[sup][13][/sup] These drug delivery agents have been shown to effectively target cancer cells in vitro.[sup][14][/sup] It is hypothesized that VLPs may accumulate in tumor sites due to the enhanced permeability and retention effect, which could be useful for drug delivery or tumor imaging.

Quote:    Assembly - The understanding of self-assembly of VLPs was once based on viral assembly. This is rational as long as the VLP assembly takes place inside the host cell (in vivo), though the self-assembly event was found in vitro from the very beginning of the study about viral assembly.[sup][33][/sup] Study also reveals that in vitro assembly of VLPs competes with aggregation[sup][34][/sup] and certain mechanisms exist inside the cell to prevent the formation of aggregates while assembly is ongoing.[sup][35][/sup]

Quote:Joe Tippens never planned to discover a potential remedy that he credits with saving his life and thrust him into the spotlight among notable cancer survivors. The 67-year-old businessman told The Epoch Times he just wanted to beat a type of cancer with an extremely low survival rate.
In August 2016, Tippens was diagnosed with small cell lung cancer with a fist-sized tumor. After undergoing chemotherapy and radiation five times a week in Houston, the large tumor in his left lung was eliminated. However, Tippens said the treatments came closer to killing him than curing him.
When he returned home to Oklahoma after the New Year, he received devastating news. His oncologist told him he had zero chance of surviving for more than a few months.

“In January of 2017, my PET scan lit up like a Christmas tree and I had wide metastasis everywhere, including in my neck, bones, pancreas, and liver,” Tippens said.
Finding a Lifeline
Facing a prognosis of three months to live, Tippens heard an intriguing story from a veterinarian he knew: A scientist with terminal cancer reportedly cured her lab mice and then herself using fenbendazole, an antiparasitic drug.

Joe Tippens, an Oklahoma-based businessman, has helped numerous cancer patients after he was cured partly by taking fenbendazole. Photo courtesy of Joe Tippens

The story was the beginning of what eventually became the “Joe Tippens Protocol.”
Fenbendazole, used for 30 years to treat intestinal parasites in animals, has not received U.S. Food and Drug Administration (FDA) approval for human use, meaning doctors cannot prescribe it for people. However, with a terminal diagnosis and nothing to lose, Tippens decided to try it alongside his conventional treatments.
Tippens found that Panacur, a trade name for fenbendazole, was sold over the counter at outlets that carry veterinary medications.
Starting in the third week of January 2017, Tippens began taking the canine medication, Panacur, 1 gram per day for three consecutive days per week. After four days without the medication, which contains about 222 milligrams of fenbendazole per gram, he would repeat his three-day routine. Three months later, Tippens was cancer-free.
His protocol also included Theracurmin, a form of the active compound in turmeric, and CBD, an extract of cannabis which does not cause intoxication.
Scientific Support and Mechanisms
Dr. William Makis, an oncologist and cancer researcher based in Edmonton, Canada, has studied Tippens’s approach and treats cancer patients worldwide, primarily through telehealth.
“I’ve had several patients declared cancer-free after doing the protocol for a number of months,” Makis told The Epoch Times. “What made [Tippens’] situation so powerful is that he cured himself of a cancer that is very aggressive—small cell lung cancer—and he had a terminal diagnosis.”
According to Makis, the family of anti-parasitic drugs that includes fenbendazole, mebendazole, and albendazole works well—scientists have found at least 12 ways the medications can fight cancer.
The effectiveness of the drugs stems from key similarities between parasite and cancer cells: both have the capacity for autonomous survival and proliferation, resistance to cell-death pathways, and the ability to circumvent the host immune system.
Anti-parasitic drugs appear to fight cancer through multiple mechanisms:

• Boosting protein called p53: P53 is a tumor suppressor protein that helps kill cancer cells.
  
• Blocking glucose uptake: Cancer cells depend on sugar for energy and growth.
  
• Disrupting microtubules: These cellular structures are crucial for cell division of cancer cells.
  
• Affecting mitochondrial function: Depletes cellular energy, increases oxidative stress, and blocks a critical pathway that regulates cell growth of cancer cells.
  

Researchers at the Stanford University Medical Center have reported several case reports, using fenbendazole to cure Stage 4 cancer cases, Makis said. The series of case reports was published in 2021 in SciTechnol, an online, London-based publisher of scientific journal articles.
A thought-provoking review citing animal studies published in 2024 in Anticancer Research Journal concluded that fenbendazole affects energy metabolism—mainly by increasing the levels of p53 and affecting pathways that control sugar uptake. It ultimately starves cancer cells and causes them to die with minimal harm to normal cells.  The researchers concluded that fenbendazole’s effects on energy metabolism “could lead to significant advances in cancer treatment.”
Some preliminary research also suggested potential anti-cancer mechanisms for fenbendazole. A study published in Scientific Reports in 2018 by researchers in India found that fenbendazole “may be evaluated as a potential therapeutic agent because of its effect on multiple cellular pathways leading to effective elimination of cancer cells.” Specifically, fenbendazole interferes with microtubules involved in cell division.
A 2016 study published in Biochemical and Biophysical Research Communications found that ivermectin, an antiparasitic drug approved for human use, shows promise against glioblastoma, an aggressive brain cancer known for treatment resistance. The drug kills glioblastoma cells and inhibits blood vessel development. In laboratory and mouse studies, ivermectin triggers cancer cell death and significantly reduces tumor growth.
Recent research has shown that a combination of fenbendazole and diisopropylamino dichloroacetate, a compound used to treat hepatitis, has shown some anticancer properties in cell cultures and animal studies. Combined, the drugs kill lung cancer cells more effectively than either drug alone.
Makis has found that combining fenbendazole with ivermectin can increase the protocol’s effectiveness.
“When you combine them, you go from attacking cancer in a dozen ways to attacking cancer in two dozen ways,” Makis said. “I have found it very reasonable to include both of them in protocols if there is pre-clinical research that each of them has an effect [on] that particular type of cancer. Whenever you have a specific cancer, I want to look at the body of research to see if there is a proven effect of either ivermectin or fenbendazole for that type of cancer. If there is, then I share that research with my patients.”
Makis has treated patients with various cancers—from common types like breast, prostate, colon, and lung cancer to rarer forms such as cholangiocarcinoma (bile duct cancer) and sarcomas (soft tissue cancers). “I’ve had several patients declared cancer-free after doing the protocol for a number of months,” Makis said.
Although Makis has been recommending ivermectin and fenbendazole for cancer treatment, he acknowledges that many doctors refrain from this practice.
Doctors are very hesitant to help cancer patients with repurposed drugs because of repercussions from the medical boards, Makis said.
“On the other hand, you have doctors who are willing to help patients with repurposed drugs but no experience with oncology,” he said.
When asked whether he recommends that cancer patients consult with an integrative physician who approves of those treatments, Makis said it is good for a patient to have a relationship with a doctor who has experience with oncology.
“It depends on the physician’s background,” Makis said. “Some doctors have extensive experience, after seeing cancer patients for many years.”
Patient Success Stories
Donna Leland, 64, a show host on the national Moody Radio Network, was diagnosed with Stage 3 cervical and endometrial cancer in April 2023. She underwent a hysterectomy but declined the recommended chemotherapy and radiation.
“I had seen the outcome for other people who had gone that route,” Leland told The Epoch Times. “Some had gotten all cleared, but then the cancer came back. I know it diminishes your own immune system’s ability to fight off disease.”

Donna Leland, a national radio network host and cancer survivor, credits the Joe Tippens Protocol for helping her to regain her health and her husband Tom's support, a retired Chicago Police sergeant. Huey Freeman/The Epoch Times

Leland told the doctor she did not want those treatments and asked for another option. But she was offered nothing else.
“I knew there had to be a better way than to fry everything. I just said, ‘I’d rather die than fry.’”
Leland began taking fenbendazole and ivermectin. She also found support from Terry Harmon, a chiropractor and functional medicine physician in Kentucky.
Harmon says more than 100 of his patients have reported positive health benefits from using fenbendazole or ivermectin.
“The reason so many people are finding success is twofold,” Harmon told The Epoch Times. “It is addressing infections. It helps the body heal and get stronger. There is research showing this combination helps the body’s ability genetically to kill cancer and prevent cancer from growing and spreading.”
Leland said she had confirmation of the effectiveness of these alternative treatments from studies on ivermectin, fenbendazole, and other anti-parasitic drugs. Mebendazole is another anti-parasitic drug that both Makis and Harmon recommended as an effective cancer treatment.
One year after her hysterectomy, Leland said she is healthier than she has ever been, partly because of her continuing use of anti-parasitic drugs for preventive purposes.
“After being checked every three months for evidence of cancer, my oncologist continues to declare me cancer-free.”
“I feel like I’m 20 years younger,” Leland said. “God has been faithful to lead me on this journey.” 
Global Impact
The Tippens Protocol has achieved significant international reach, particularly in China, where a translated blog has garnered more than 20 million views. This has led to an estimated 70,000 followers of what’s affectionately called the “Uncle Joey Protocol.”
Despite opportunities to monetize his discovery, Tippens has refused all financial gain.
“I have had search engine experts who have told me I could monetize this blog to the tune of $25,000 to $30,000 per month,” he said. “I can’t do that for a simple reason: I have hundreds of people who have told me the reason they believe me and trust me is because I am doing all this and not monetizing it. The second I monetized it, I would be just another guy out there hawking product out on the Internet, trying to make money.”
Tippens warns about fraudulent Facebook pages that falsely use his name to sell substandard drugs.
Regulatory and Medical Challenges
The FDA confirmed that it has not approved “drug products containing fenbendazole for use in humans,” said Lauren-Jei McCarthy, FDA press officer, in a statement to The Epoch Times. It has not gone through the rigorous testing and clinical trials required for drugs intended for human use. Fenbendazole is approved by the FDA as an antiparasitic drug for use in animals. It is commonly used to deworm dogs, cats, horses, and cattle.
Ivermectin, while FDA-approved for human use against parasitic worms, is not approved for cancer treatment. Health care providers may prescribe ivermectin to fight cancer as a repurposed medication. Both medications are available without prescriptions and are routinely purchased for veterinary use.
Makis, who has been at the cutting edge of advocating for holistic treatments that include the repurposed drugs, said he believes we are in a revolutionary era of effective cancer treatments.
“This is the first time in several generations there is a strong movement for true medical freedom, to allow for exploration of treatments that don’t benefit any big company,” he said.
Related Stories
[/url]Anti-Parasitic Drug Can Be Used for COVID-19 in South Africa; WHO Says Use in Studies Only


Anti-Parasitic Drug Ivermectin Kills COVID-19 in Lab
[url=https://www.theepochtimes.com/article/anti-parasitic-drug-ivermectin-kills-covid-19-in-lab-3296729?ea_src=author_manual&ea_med=related_stories]

Serious side effects from fenbendazole and ivermectin are rare, Makis said.
“I have seen moderate side effects, which include unpleasant visual symptoms, some dizziness, and fatigue,” Makis said.
Tippens is encouraged by ongoing research into other FDA-approved drugs that might be repurposed for cancer treatment.
“Because of my story, I think there are other efforts in research in the anti-parasitic category,“ Tippen said. ”There are seven sister drugs to fenbendazole. One medical group has used mebendazole in their protocol. I think I’ve started at least opening people’s brains to something.”